Impact of COVID-19 on the Diagnosis and Management of Multiple Myeloma: Experience from a Canadian Center
Document title: Impact of COVID-19 on the Diagnosis and Management of Multiple Myeloma: Experience from a Canadian Center
Journal: Revista de investigación clínica
Database: PERIÓDICA
System number: 000452989
ISSN: 0034-8376
Authors: 1
1
1
1
1
1
1
1
1
1
1
Institutions: 1Tom Baker Cancer Center, Department of Medical Oncology and Hematology, Calgary, Alberta. Canadá
Year:
Season: Ene-Feb
Volumen: 74
Number: 1
Pages: 16-22
Country: México
Language: Inglés
Document type: Artículo
Approach: Analítico, descriptivo
English abstract Background: The impact of coronavirus disease-19 on the management of multiple myeloma (MM) has been recognized. However, the real effect on clinical outcomes remains poorly understood. Objective: We describe a local experience of the management of MM patients and report their outcomes during the current pandemic. Methods: All consecutive symptomatic MM patients seen at our center since 03/20 were evaluated. Results: A cohort of 156 patients diagnosed from 01/19 to 12/20 was analyzed to interrogate differences in presentation patterns. A total of 553 MM patients were seen and/or treated at Tom Baker Cancer Center in the year of 2020. From those, 47.1% (n = 261) were tested for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Sixteen patients tested positive and data are presented. In addition, a decrease of 21.7% in the rate of new smoldering MM/MM diagnosis was observed in 2020 as compared to 2019. Further, an increase in deaths was also observed in 2020. Conclusions: Our study confirms an increase lethality for MM patients infected with SARS-CoV-2. A balance between safety and need for cancer control should be emphasized
Disciplines: Medicina
Keyword: Neurología,
Virus,
Diagnóstico,
Mieloma múltiple,
SARS-CoV-2,
COVID-19
Keyword: Neurology,
Virus,
Diagnosis,
Multiple myeloma,
SARS-CoV-2,
COVID-19
Full text: Texto completo (Ver HTML) Texto completo (Ver PDF)